Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.
A major aim in immunology has been to understand how the immune system evokes characteristic responses to infection, foreign tissue grafts and tumours. The current view of immunoregulation is based mainly on studies of lymphocyte subsets, either in vitro or by adoptive transfer to irradiated recipie...
Main Authors: | Cobbold, S, Jayasuriya, A, Nash, A, Prospero, T, Waldmann, H |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1984
|
Similar Items
-
Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system.
by: Nash, A, et al.
Published: (1987) -
Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.
by: Cobbold, S, et al.
Published: (1986) -
SUPPRESSION OF LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES IN MICE BY MONOCLONAL-ANTIBODIES TO LYMPHOCYTE-T SUBSETS
by: Kantwerk, G, et al.
Published: (1986) -
Monoclonal-antibody therapy in systemic vasculitis.
by: Mathieson, P, et al.
Published: (1990) -
Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potential.
by: Isaacs, J, et al.
Published: (1992)